Search Results

Biotech Beach

Rakuten Medical Announces Poster Presentation and Booth Exhibition at ASCO 2024 Annual Meeting

Rakuten Medical, Inc today announced that it will present a poster at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting (ASCO 2024), which will be held in Chicago, Illinois from May 31 through June 4, 2024.

May 9, 2024

·

5 min read

Biotech Beach

Rakuten Medical’s Poster Presentation at AACR 2024 Demonstrates Reduction in Photoimmunotherapy-induced Edema in Mice with COX-2 Inhibition

Rakuten Medical, Inc. announced a poster presentation of its study to manage edema following photoimmunotherapy at the 115th Annual Meeting of the American Association for Cancer Research in San Diego, California, on April 8th, 2024.

April 11, 2024

·

7 min read

Biotech Beach

Rakuten Medical to Host R&D Day Highlighting Recent Interim Data from Phase 1b/2 Clinical Trial of ASP-1929 Photoimmunotherapy in Combination with anti-PD-1 in r/m HNSCC

Rakuten Medical, Inc. today announced that it will host a virtual R&D Day on Thursday, June 20, 2024 at 1:00 pm ET / 10:00 am PT.

May 29, 2024

·

5 min read

Biotech Beach

Rakuten Medical Closes $119 Million Series E Financing to Further Develop its Alluminox™ Platform

Rakuten Medical, Inc. announced the completion of a $119 million Series E preferred stock financing, including $45 million in new capital and the conversion of $74 million of convertible promissory notes with accrued interest.

March 6, 2024

·

7 min read

Press Releases

Rakuten Medical Announces New Management Team to Drive the Next Phase of Growth and Innovation

August 20, 2024

·

7 min read

Drug Development

Rakuten Medical Announces Recent Interim Data from Phase 1b/2 Clinical Trial of ASP-1929 Photoimmunotherapy in Combination with anti-PD-1 for First Line Recurrent and/or Metastatic Head and Neck Cancer to be Presented at ASCO 2024

Rakuten Medical, Inc. announced the updated safety and efficacy findings from an interim evaluation of an open-label Phase 1b/2 study of photoimmunotherapy using ASP-1929 in combination with anti-PD-1 for recurrent and/or metastatic head and neck squamous cell carcinoma.

May 24, 2024

·

8 min read

Press Releases

Rakuten Medical Presented Research Results of Preclinical Studies for PD-L1-Targeted Photoimmunotherapy at The 83rd Annual Meeting of The Japanese Cancer Association 2024

September 20, 2024

·

7 min read

Biotech Beach

Rakuten Medical to Present at 2023 Jefferies London Healthcare Conference on November 14

Rakuten Medical, Inc. announced that the Company will present at the 14th Annual Jefferies London Healthcare Conference being held in London, UK, on November 14-16, 2023.

November 2, 2023

·

2 min read

Biotech Beach

Rakuten Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 10th, 2024

Rakuten Medical, Inc., a global biotechnology company developing and commercializing precision, cell-targeting photoimmunotherapy treatments based on its proprietary Alluminox™ platform, today announced that the Company will present at the 42nd Annual J.P. Morgan Healthcare Conference being held January 8-11, 2024.

December 13, 2023

·

4 min read

Biotech Beach

Rakuten Medical Presents AI-based Study in Two Posters on Immune Characteristics in Responders and Cellular Level Drug Quantification of Alluminox Treatment (Photoimmunotherapy) at SITC 2023

Rakuten Medical, Inc. today announced the presentation of two posters of AI-based analyses at the 38th Annual Meeting of the Society for Immunotherapy of Cancer (SITC), held November 3-5, 2023, in San Diego, CA (SITC 2023).

November 6, 2023

·

8 min read